Control of osteoblast function and regulation of bone mass (original) (raw)

• Neer, R. M. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344, 1434–1441 (2001).
  Article CAS PubMed Google Scholar
• Rodan, G. A. Bone mass homeostasis and bisphosphonate action. Bone 20, 1–4 (1997).
  Article CAS PubMed Google Scholar
• Ehrlich, P. J. & Lanyon, L. E. Mechanical strain and bone cell function: a review. Osteoporosis Int. 13, 688–700 (2002).
  Article CAS Google Scholar
• Pavalko, F. M. et al. A Model for mechanotransduction in bone cells: The load-bearing mechanosomes. J. Cell. Biochem. 88, 104–112 (2003).
  Article CAS PubMed Google Scholar
• Riggs, B. L., Khosla, S. & Melton, L. J. III Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23, 279–302 (2002).
  Article CAS PubMed Google Scholar
• Schmidt, A., Harada, S. & Rodan, G. A. in Principles of Bone Biology (eds Bilezikian, J. P., Raisz, L. G. & Rodan, G. A.) 1455–1466 (Academic, San Diego, 2002).
  Google Scholar
• Frost, H. M. Cybernetic aspects of bone modeling and remodeling with special reference to osteoporosis and whole-bone strength. Am. J. Hum. Biol. 13, 235–248 (2001).
  Article CAS PubMed Google Scholar
• Martin, T. J. & Rodan, G. A. in Osteoporosis (eds Marcus, R., Feldman, D. & Kelsey, J.) 361–371 (Academic, San Diego, 2002).
  Google Scholar
• Pocock, N. A. et al. Genetic determinants of bone mass in adults. A twin study. J. Clin. Invest. 80, 706–710 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Seeman, E. et al. Reduced bone mass in daughters of women with osteoporosis. N. Engl. J. Med. 320, 554–558 (1989).
  Article CAS PubMed Google Scholar
• Ralston, S. H. Genetic control of susceptibility to osteoporosis. J. Clin. Endocrinol. Metab. 87, 2460–2466 (2002).
  Article CAS PubMed Google Scholar
• Mosekilde, L. Consequences of the remodelling process for vertebral trabecular bone structure: a scanning electron microscopy study (uncoupling of unloaded structures). Bone Miner. 10, 13–35 (1990).
  Article CAS PubMed Google Scholar
• Wallace, B. A. & Cumming, R. G. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif. Tissue Int. 67, 10–18 (2000).
  Article CAS PubMed Google Scholar
• Kontulainen, S. et al. Good maintenance of exercise-induced bone gain with decreased training of female tennis and squash players: a prospective 5-year follow-up study of young and old starters and controls. J. Bone Miner. Res. 16, 195–201 (2001).
  Article CAS PubMed Google Scholar
• Ducy, P. et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197–207 (2000).
  Article CAS PubMed Google Scholar
• Corral, D. A. et al. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc. Natl Acad. Sci. USA 95, 13835–13840 (1998).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Takeda, S. et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305–317 (2002).
  Article CAS PubMed Google Scholar
• Thomas, T. et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140, 1630–1638 (1999).
  Article CAS PubMed Google Scholar
• Burguera, B. et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142, 3546–3553 (2001).
  Article CAS PubMed Google Scholar
• Khosla, S. Leptin-central or peripheral to the regulation of bone metabolism? Endocrinology 143, 4161–4164 (2002).
  Article CAS PubMed Google Scholar
• Bliziotes, M. et al. Bone histomorphometric and biomechanical abnormalities in mice homozygous for deletion of the dopamine transporter gene. Bone 26, 15–19 (2000).
  Article CAS PubMed Google Scholar
• Baldock, P. A. et al. Hypothalamic Y2 receptors regulate bone formation. J. Clin. Invest. 109, 915–921 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Thorsell, A. & Heilig, M. Diverse functions of neuropeptide Y revealed using genetically modified animals. Neuropeptides 36, 182–193 (2002).
  Article CAS PubMed Google Scholar
• Mahns, D. A., Lacroix, J. S. & Potter, E. K. Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs. J. Auton. Nerv. Syst. 73, 80–85 (1998).
  Article CAS PubMed Google Scholar
• Smith-White, M. A., Herzog, H. & Potter, E. K. Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission. Regul. Pept. 103, 105–111 (2002).
  Article CAS PubMed Google Scholar
• Flier, J. S. Physiology: is brain sympathetic to bone? Nature 420, 619–622 (2002).
  Article ADS CAS PubMed Google Scholar
• Minkowitz, B., Boskey, A. L., Lane, J. M., Pearlman, H. S. & Vigorita, V. J. Effects of propranolol on bone metabolism in the rat. J. Orthop. Res. 9, 869–875 (1991).
  Article CAS PubMed Google Scholar
• Schwartzman, R. J. New treatments for reflex sympathetic dystrophy. N. Engl. J. Med. 343, 654–656 (2000).
  Article CAS PubMed Google Scholar
• Ducy, P., Schinke, T. & Karsenty, G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 289, 1501–1504 (2000).
  Article ADS CAS PubMed Google Scholar
• Rosen, E. D. & Spiegelman, B. M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16, 145–171 (2000).
  Article CAS PubMed Google Scholar
• Arnold, H. H. & Winter, B. Muscle differentiation: more complexity to the network of myogenic regulators. Curr. Opin. Genet. Dev. 8, 539–544 (1998).
  Article CAS PubMed Google Scholar
• Karsenty, G. & Wagner, E. F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389–406 (2002).
  Article CAS PubMed Google Scholar
• Akiyama, H., Chaboissier, M. C., Martin, J. F., Schedl, A. & de Crombrugghe, B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813–2828 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. & Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747–754 (1997).
  Article CAS PubMed Google Scholar
• Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755–764 (1997).
  Article CAS PubMed Google Scholar
• Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765–771 (1997).
  Article CAS PubMed Google Scholar
• Inada, M. et al. Maturational disturbance of chondrocytes in _Cbfa1_-deficient mice. Dev. Dyn. 214, 279–290 (1999).
  Article CAS PubMed Google Scholar
• Ueta, C. et al. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J. Cell Biol. 153, 87–100 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Takeda, S., Bonnamy, J. P., Owen, M. J., Ducy, P. & Karsenty, G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15, 467–481 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17–29 (2002).
  Article CAS PubMed Google Scholar
• Jheon, A. H., Ganss, B., Cheifetz, S. & Sodek, J. Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development. J. Biol. Chem. 276, 18282–18289 (2001).
  Article CAS PubMed Google Scholar
• Kundu, M. et al. Cbfβ interacts with Runx2 and has a critical role in bone development. Nature Genet. 32, 639–644 (2002).
  Article CAS PubMed Google Scholar
• Yoshida, C. A. et al. Core-binding factor β interacts with Runx2 and is required for skeletal development. Nature Genet. 32, 633–638 (2002).
  Article CAS PubMed Google Scholar
• Bendall, A. J. & Abate-Shen, C. Roles for Msx and Dlx homeoproteins in vertebrate development. Gene 247, 17–31 (2000).
  Article CAS PubMed Google Scholar
• Robledo, R. F., Rajan, L., Li, X. & Lufkin, T. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev. 16, 1089–1101 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Grigoriadis, A. E., Wang, Z. Q. & Wagner, E. F. Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet. 11, 436–441 (1995).
  Article CAS PubMed Google Scholar
• Jochum, W. et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nature Med. 6, 980–984 (2000).
  Article CAS PubMed Google Scholar
• Sabatakos, G. et al. Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nature Med. 6, 985–990 (2000).
  Article CAS PubMed Google Scholar
• Ducy, P. et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13, 1025–1036 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Geoffroy, V., Kneissel, M., Fournier, B., Boyde, A. & Matthias, P. High bone resorption in adult aging transgenic mice overexpressing Cbfa1/Runx2 in cells of the osteoblastic lineage. Mol. Cell. Biol. 22, 6222–6233 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, W. et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155, 157–166 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Little, R. D. et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70, 11–19 (2002).
  Article CAS PubMed Google Scholar
• Boyden, L. M. et al. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513–1521 (2002).
  Article CAS PubMed Google Scholar
• Gong, Y. et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513–523 (2001).
  Article CAS PubMed Google Scholar
• Kato, M. et al. _Cbfa1_-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157, 303–314 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hey, P. J. et al. Cloning of a novel member of the low-density lipoprotein receptor family. Gene 216, 103–111 (1998).
  Article CAS PubMed Google Scholar
• Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J. & Skarnes, W. C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407, 535–538 (2000).
  Article ADS CAS PubMed Google Scholar
• Mao, J. et al. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol. Cell 7, 801–809 (2001).
  Article CAS PubMed Google Scholar
• Bain, G., Muller, T., Wang, X. & Papkoff, J. Activated β-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 301, 84–91 (2003).
  Article CAS PubMed Google Scholar
• Zorn, A. M. Wnt signalling: antagonistic Dickkopfs. Curr. Biol. 11, R592–R595 (2001).
  Article CAS PubMed Google Scholar
• Hadjiargyrou, M. et al. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J. Biol. Chem. 277, 30177–30182 (2002).
  Article CAS PubMed Google Scholar
• Van Wesenbeeck, L. et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am. J. Hum. Genet. 72, 763–771 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Balemans, W. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537–543 (2001).
  Article CAS PubMed Google Scholar
• Brunkow, M. E. et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68, 577–589 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Balemans, W. & Van Hul, W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250, 231–250 (2002).
  Article CAS PubMed Google Scholar
• Rodan, G. A. & Martin, T. J. Therapeutic approaches to bone diseases. Science 289, 1508–1514 (2000).
  Article ADS CAS PubMed Google Scholar
• Mao, B. et al. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature 417, 664–667 (2002).
  Article ADS CAS PubMed Google Scholar